DOI: 10.1055/s-00000031

Klinische Monatsblätter für Augenheilkunde

References

Hattenbach LO, Friedrich Arndt C, Lerche R. et al.
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

Retina 2009;
29: 932-940

Hattenbach LO, Friedrich Arndt C, Lerche R. et al.
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

Retina 2009;
29: 932-940

Download Bibliographical Data

Search in:
Access: